Large-Scale Digital Health Platform Trial Targets 'Three Highs' in Taiwan — Novel Approach to Cardiovascular Risk Management

References

1. 1.New Taipei City Medical Association. (2024). New Taipei City 888 Digital Medical AI Platform for the Prevention and Treatment of the Three Highs (Hypertension, Hyperglycemia, Hyperlipidemia) and Cardio-Renal-Vascular Diseases. ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT07588256
2. 2.Parati, G., Stergiou, G., O'Brien, E., Asmar, R., Atkins, N., Bilo, G., ... & Zhang, Y. (2021). European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. Journal of Hypertension, 39(7), 1384-1406. https://doi.org/10.1097/HJH.0000000000002922
3. 3.SPRINT Research Group. (2015). A randomized trial of intensive versus standard blood-pressure control. New England Journal of Medicine, 373(22), 2103-2116. https://doi.org/10.1056/NEJMoa1511939
4. 4.Zhang, W., Zhang, S., Deng, Y., Wu, S., Ren, J., Sun, H., ... & STEP Study Group. (2021). Trial of intensive blood-pressure control in older patients with hypertension. New England Journal of Medicine, 385(14), 1268-1279. https://doi.org/10.1056/NEJMoa2111437
5. 5.Stergiou, G. S., Palatini, P., Parati, G., O'Brien, E., Januszewicz, A., Lurbe, E., ... & Mancia, G. (2021). 2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement. Journal of Hypertension, 39(7), 1293-1302. https://doi.org/10.1097/HJH.0000000000002843